Dana J. Moss - Nov 16, 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Director
Signature
Gioia Gentile on behalf of Dana J. Moss, by power of attorney
Stock symbol
NAVB
Transactions as of
Nov 16, 2023
Transactions value $
$0
Form type
4
Date filed
11/20/2023, 06:43 PM
Previous filing
Jul 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +200K +80% $0.00 450K Nov 16, 2023 Direct F1
transaction NAVB Common Stock Award $0 +417K +92.59% $0.00 867K Nov 16, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares vest on the one-year anniversary of the Grant Date, subject to the Reporting Person's continuous service to the Company.
F2 Shares vest in three equal tranches, with the first tranche vesting on July 11, 2024 (the "Initial Vesting Date"), with the remaining tranches vesting ratably annually from the Initial Vesting Date over the following two years, subject to the Reporting Person's continuous service to the Company.